Oops!

You don't have permission to view this page! Make sure you're logged in and try again, or contact support.

Share on
Share on LinkedIn Share on WhatsApp

RELATED

Roundtable Sessions

Lung Cancer by Solange Peters
Dec 17 2024
Lung Cancer

Lung Cancer 2024 REVIEW

} 1 h 43 min

watch now
Uro-Onkologie von Aurelius Omlin
Nov 15 2024
Urogenital

Urogenitale Tumore

} 2 h 19 min

watch now
ADCs by Alessandra Curioni
Nov 06 2024
Antibody Drug Conjugates

Antibody Drug Conjugates

} 1 h 39 min

watch now
GYNE Session by Apostolos Sarivalasis
Sep 26 2024
Women's Cancers

Gynecological Cancers

} 1 h 32 min

watch now
Breast Session by Jens Huober
Jul 02 2024
Women's Cancers

Breast Cancer (ASCO 2024)

} 1 h 34 min

watch now
OncoViews on GI Cancers by Thibaud Kössler
Jun 19 2024
Gastrointestinal

GI Cancers (ASCO 2024)

} 1 h 31 min

watch now
OncoViews on Lung Cancer by Alfredo Addeo
Jun 12 2024
Lung Cancer

Lung Cancer (ASCO 2024)

} 1 h 32 min

watch now
HER2 Session by Ilaria Colombo
Apr 30 2024
Biomarkers

HER2 in Lung, GYNE & GI Cancers

} 1 h 34 min

watch now
GU Session by Aurelius Omlin
Mar 27 2024
Urogenital

Prostate & Urothelial Cancer

} 1 h 32 min

watch now
Biomarker Session by Sabina Berezowska
Feb 06 2024
Biomarkers

Biomarkers in GI & Lung

} 1 h 45 min

watch now

UPCOMING

Join us for
our roundtable in
||
latest advances in
||
your questions on
||
new therapies for
||
practice changes in
||
your patient cases in

MPN

Gabriela Baerlocher

Hirslanden Clinic Zurich, Switzerland

Sara Meyer

Inselspital, University Hospital Bern, Switzerland

AGENDA

Managing PV and MF: Integrating interferons, immunotherapies and new JAK2 inhibitors

Sara Meyer

Clinical significance of genomic testing in MPN: When to test what and what does it really mean?

TBD

Update on the management of CML: Navigating through the available and upcoming treatment options

Gabriela Baerlocher

2 CME Points by

SWISS SOCIETY OF HEMATOLOGY
(SGH • SSH)

Join our host, Sara Meyer, for an insightful roundtable on the latest progress in the treatment of myeloproliferative neoplasms (MPNs). This interdisciplinary roundtable gathers renowned experts to discuss groundbreaking findings, offering an in-depth exploration of new innovative therapeutic approaches for myelofibrosis, polycythaemia vera and chronic myeloid leukemia. Don’t miss this opportunity to enhance your understanding, engage in the discussion, and uncover the pivotal developments transforming the treatment landscape of myeloproliferative neoplasms.

ADD THIS TO YOUR CALENDAR

Register here

Do You Have An Account Already?
No need to sign up again: as a verified OncoViewer, you will have access to all our upcoming sessions. Simply login to participate in this session.

First Time On OncoViews?

Get Registered Now